Expert clinicians will share their experience with the therapeutic management of auto-immune neurological diseases using therapeutic plasma exchange (TPE), including evidence-based clinical practice and patient cases.

09/11/2021
Expert clinicians will share their experience with the therapeutic management of auto-immune neurological diseases using therapeutic plasma exchange (TPE), including evidence-based clinical practice and patient cases.
Join Us on 17 November 2021
 
  
Time
11:30 to 13:00 – Bangkok, Thailand
12:30 to 14:00 – Singapore, Malaysia, Hong Kong
13:30 to 15:00 – Seoul, South Korea
15:30 to 17:00 – Sydney, Australia
 
Chairperson
Dr. Fu Liong Hiew, Consultant Neurologist, Sunway Medical Centre, Kuala Lumpur, Malaysia
 
Topics and Speakers
Myasthenia Gravis: Current Real-World Evidence and Best Practices
Prof. Saiju Jacob, University Hospitals Birmingham, Birmingham, United Kingdom

Clinical Pearls: Neuromyelitis Optica Spectrum Disorders versus Anti-Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndromes versus Acute Disseminated Encephalomyelitis
Dr. Anu Jacob, Cleveland Clinic, Abu Dhabi, United Arab Emirates

Neurological Phenomenology Associated with SARS-CoV-2 Disease: A Snapshot on Encephalopathy
Dr. Tien Lee Ong, Hospital Sungai Buloh, Sungai Buloh, Malaysia

Auto-immune Neurological Diseases and SARS-CoV-2 Disease
Dr. Jasmine Koh, National Neuroscience Institute, Singapore
 
This live webinar will be available in English only.